Medtech Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

February Announcements On UK’s Medtech Regulatory System Change Awaited

UKCA regulatory update from industry: January 2023

Executive Summary

Much preparation work is underway among industry and the authorities as the UK seeks to nail down what kind of medtech regulatory system it wants for the future. Hosting an update session were the ABHI’s Phil Brown and Steve Lee.

You may also be interested in...



UK Proposal On Foreign Device Approval Recognition Due February

The Life Sciences Council has agreed to issue proposals on how the UK should recognize approvals granted by other trusted medical device regulatory jurisdictions. The need for speed in all matters relating to the UK’s sovereign medtech regulatory system has been stressed by the UK devices industry.

German Reimbursement Reform: Hospitals Hit Back

Architects of the major reform of secondary care reimbursement have asked for the input of hospitals just once, the DKG hospital federation complains. Meanwhile, many clinics are reportedly facing insolvency later this year.

The E in ESG: Medtechs Are Getting To Grips With The ‘True Purpose’ Of Carbon Zero

BD and Boston Scientific exemplify the approach of “big medtech” as it knuckles down to meet global climate change responsibilities. But the industry will have to work together with health systems to achieve the larger race to zero goals – especially those of scope 3.

Topics

Latest Headlines
See All
UsernamePublicRestriction

Register

MT147561

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel